Metraipolis › archive › dc_bb0637887351
Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series… — Europe PMC PMID:41364253
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41364253
- DOI
- 10.1007/s10549-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T19:14:31.135Z
- SHA-256 of the archived text
461f1da3307b92a357ae60770ee1b851abf8af49dfa22e8662dd4c0666151273- Stable URL of this page
https://metraipolis.com/documento/dc_bb0637887351
How to cite
Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series… — Europe PMC PMID:41364253 — Europe PMC (en), https://europepmc.org/article/MED/41364253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb0637887351 (Metraipolis archive dc_bb0637887351, sha256 461f1da3307b92a357ae60770ee1b851abf8af49dfa22e8662dd4c0666151273)
BibTeX
@misc{dcbb0637887351,
title = {Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series… — Europe PMC PMID:41364253},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41364253},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb0637887351; sha256 461f1da3307b92a357ae60770ee1b851abf8af49dfa22e8662dd4c0666151273},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41364253. Agents can read the archived copy with the MCP tool read_document.